HCPCS Level IIdrugActive
J9345
Inj, retifanlimab-dlwr, 1 mg
BETOS: O1D
Effective: 2023-10-01
Description
Injection, retifanlimab-dlwr, 1 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Zynyz
Manufacturer
Incyte Corporation
HCPCS Dosage
1 MG
Billing Units
500.0000
1
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.